3. Adil A, Goyal A, Quint JM. Behcet Disease. Statpearls. 2023. https://www.ncbi.nlm.nih.gov/books/NBK470257/
4. Kone-Paut I, Barete S, Bodaghi B, et al. French Recommendations for the Management of Behçet’s Disease. Orphanet J Rare Dis. 2021;16(Suppl 1):352 DOI: https://doi.org/10.1186/s13023‑020‑01620‑4
7. Tong B, Liu X, et al. Immunopathogenesis of Behcet's Disease. Front Immunol. 2019;10(665):1-12 DOI:10.3389/fimmu.2019.0066
8. Mattioli I, Bettiol A, et al. Pathogenesis of Behcet's Syndrome: Genetic, Environmental, and Immunological Factors. Front Med. 2021;8(713052):1-8 DOI:10.3389/fmed.2021.713052
9. Perazzio S F, Allenspach E J, Eklund K K, et al. Behçet Disease (BD) and BD-like Clinical Phenotypes: NF-κB Pathway in Mucosal Ulcerating Diseases. Scand J Immunol. 2020; 92(e12973):1-14 DOI: https://doi.org/10.1111/sji.12973
11. Al-Musawi H, et al. Behcet Disease: A Clinical Review. Journal of University of Babylon for Pure and Applied Sciences. 2020; 28(2):172-189
12. Khoshbakht S, Baskurt D, et al. Behçet’s Disease: A Comprehensive Review on the Role of HLA-B*51, Antigen Presentation, and Inflammatory Cascade. Int J Mol Sci. 2023; 24(16382):1-24 DOI: https://doi.org/10.3390/ijms242216382
13. Williams DS. Behcet's Disease. J Insur Med. 2019; 48:103–105
14. Hou Cheng-cheng, Ye Jing-fen, et al. Clinical characteristics and risk factors of intestinal involvement in Behçet’s syndrome patients: a cross-sectional study from a single center. Orphanet J Rare Dis. 2021; 16(132):1-10 DOI: https://doi.org/10.1186/s13023-021-01772-x